Company intelligence / Profile preview

CooperVision

Pleasanton, California, USAcoopervision.com ↗

Ownership: Public · COO
Employees: ~9000
Development stage: Other

Overview

CooperVision’s products are globally commercialized and include a broad portfolio of daily disposable, two-weekly, and monthly soft contact lenses. Notably, its MiSight lens for myopia control has demonstrated efficacy in slowing the progression of myopia in children over three years in randomized clinical trials.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

Collaborations with academic institutions on artificial cornea researchPartnerships with optometrists/eye care professionals worldwideNo major pharma partnerships reported.

Beyond the preview

Go deeper on CooperVision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CooperVision.

Explore the full profile